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We have broadened the utili ty of the SEQUEST computer , thm to permit correlati on of
uninterpreted high-energy collision-induced dissociation .a of peptides w ith all se-
quences in a database. SEQUEST now allows for the additi. .ragrnent ion types observed
under high-energy conditions. We analyzed spectra from pel- .des isolated following trypsin
d igestion of 13 proteins. SEQUEST ranked the correct sequence first for 90% (18/ 20) of the
spectra in searches of the OWL database, without constraint by enzyme cleavage specificity or
species of origin . All false-positives were flagged by the scoring system. SEQUEST searches
databases for sequences that correspond to the precursor ion mass ± 0.5 u. Preliminary
ranking of the top 500 candidates is done by calculation of fragment ion masses for each
sequence, and comparison to the measured ion masses on the basis of ion series con tinuity,
summed ion intensity, and immonium ion presence. Final ranking is done by construction of
model spectra for the 500 cand idates and constructing/performing of a cross-correlation
analysis with the actual spectrum. Given the need to relate mounting genome sequence
information with corresponding suites of proteins that comprise the cellular molecular
machinery, tandem mass sp ectrometry appears destined to pla y the leading role in accelerat-
ing protein identification on the large scale required . © 1996 American Society for Mass
Spectrometry (J Am Soc Mass Spectrom 1996, 7, 1089-1098)
The rapid progress in genome sequencing of avariety of organisms is producing a vast se-quence infrastructure intended to facilitate the
identification of genes and elucidation of their biologi-
cal function [1]. To eventually understand gene fun c-
tion-dysfunction, correlation with expression of the
corresponding protein through biochemical experi-
mentation at the cell or tissue level is required. There
are estimated to be - 250 specific cell types in hu-
mans, each of which expresses and regulates a subset
of the - 100,000 human genes as proteins [2]. Hence,
understanding such vast numbers of proteins, their
functions, and interconversions throughout the life of a
cell provides a challenge on a scale much larger than
the genome sequencing efforts. Because proteins actu-
ally carry out most cellular processes, it is of prima ry
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importance to focus on establishing their identity and
physiologically active forms. This goal represents a
major experimental challenge that is not addressed
readily by classical methods of protein sequencing [3].
Although clearly a daunting task, it has recently be-
come apparent that this problem ma y be addressed by
using tandem mass spectrometry to rapidly determine
both partial and complete sequence [4-7], despite early
concerns about the extent of expertise required to
interpret the tandem ma ss spectra of peptides. Further-
more, sequence information provides far more discrim-
inating power to search databases than peptide-mass
fingerprinting approaches [8-12]. Sequence data also
substantially increases the success rate and certainty in
protein identification experiments to the point where
only a single peptide may be necessary (assuming the
presence of onl y a single protein in the sample) [4, 5).
Recent instrumental innovations have brought about
the availability of a variety of tandem mass spectro-
metric methods for the generation of peptide fragm en-
tation information that enables determination, to vary-
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ing extents, of a peptide's sequence and accompanying
covalent modifications. In general, these methods em-
ploy either low-energy 00-100 eV) [13, 14] or high-
energy OOOO-SOOO eV) [IS-IS] collisions with neutral
atoms to induce dissociation of the protonated molecu-
lar ion, or analyze the metastable (postsource decay)
fragment ions formed from excess energy deposition
during matrix-assisted laser desorption ionization
(MALOn [19]. The fragmentation patterns produced
by using high-energy collisions, such as those ob-
served on tandem double-focusing [15], double-focus-
ing-orthogonal acceleration time-of-flight (TOF) [16],
and collision cell equipped reflectron TOF [IS] mass
spectrometers contain a wider range of fragment ion
types than is observed under low-energy collision-
induced dissociation (CIO) conditions or MALOI
metastable conditions. By using low-energy conditions,
the main fragment ions observed are associated with
cleavage of the peptide backbone. Such cleavages pro-
duce sequence ions that exhibit charge retention either
on the N-terminal portion of the peptide (a, b, and c
ions) or on the C-terminal portion (x, y, and z Ions)
[15, 20]. High-energy cm of peptides usually gener-
ates additional tyles of fragments that arise from
cleavage of the '[3- or 'Y-carbon atoms for certain
residues referred to as "satellite" sequence ions [15,
20]. These side-chain cleavages are labeled as either d
or v and w ions depending on whether the charge
(basic residue) is preferentially located on the N- or
C-terminal moiety, respectively. In low-energy CIO
and MALDI metastable [21] mass spectra, neither c, x,
and z-type ions nor side-chain cleavages usually are
observed. These additional fragmentation pathways
seen by using high-energy collision conditions result in
more spectral complexity, but provide more detailed
structural information facilitating unambiguous se-
quence determination. Consequently, computer algo-
rithms have been developed to assist in the analysis of
high-energy CIO spectra [20, 22-24]. These range from
computer algorithms that calculate the expected mass-
to-charge ratio values for a given sequence to pro-
grams designed to aid in the de novo determination of
unknown sequences. As long as the peptide is derived
from a known protein, database search strategies tend
to be more successful than de novo interpretation
strategies. Inability to discriminate among sequence
permutations because of spectral ambiguity hinders de
novo sequence interpretation, whereas database
searches need to discriminate only between the subset
of permutations actually present in a database.
In all tandem mass spectrometric methods capable
of producing peptide fragmentation information, the
interpretation of the spectra obtained is currently the
rate-limiting step in eliciting of the desired sequence
and structural information. If one seeks to employ
automated liquid chromatography-tandem mass spec-
trometry instrumentation capable of acquiring dozens
of tandem mass spectra per hour in the current envi-
ronment of rapidly growing genomic sequence
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databases, it is essential to develop strategies that
enable rapid and direct interrogation of all known
sequences by using "raw" tandem mass spectral data
[25-27]. Although Mann and Wilm [2S] have devel-
oped a powerful method to search protein databases
through the use of peptide sequence tags determined
from partial manual interpretation of tandem mass
spectra yielding as few as two or three sequential
amino acids, Eng et al. [25] developed methods that
permit the search of protein and nucleotide sequence
databases directly by using the uninterpreted fragmen-
tation information contained in a whole tandem
mass spectrum. The utility of both approaches has
been established initially with the low-energy CID
spectra (E'ab = 10-50 eV) produced by using triple
quadrupole-type mass spectrometers that operate un-
der electrospray ionization conditions, where the pre-
dominant fragment ions are of the band y types. The
method of Eng et a1. employs a pre-search filter that
calculates the user-specified fragment ion types ex-
pected for each candidate amino acid sequence in the
database within the mass tolerance specified in the
search. In this preliminary analysis the ion types from
each candidate sequence retrieved from the database
are compared to the fragment ions present in the
tandem mass spectrum. A preliminary score is calcu-
lated based on the summed experimental ion intensity,
sequence ion continuity, and the presence of immo-
nium ions and the corresponding amino acid in a
candidate sequence. The 500 highest preliminary scor-
ing candidates then undergo further analysis that uti-
lizes a cross-correlation function. In this process a
model tandem mass spectrum is constructed for each
of these 500 candidate sequences and then compared
to the experimental tandem mass spectrum by applica-
tion of a cross-correlation function to measure the
closeness-of-fit [25]. The correct sequence is deter-
mined by using a normalized ranking of the cross-cor-
relation scores. Any possible false-positive search re-
sults may be discerned (are "flagged") from observa-
tion of a small difference « 0.1) in the normalized
cross-correlation score between the first and second
ranking sequences.
In the present study, we describe modifications to
the Eng et al. [25] computer algorithm SEQUEST that
allow the search of protein databases with high-energy
CIO spectra that may contain fragment ions of the a, b,
c, d, o, ui, x, y, and z types. The results are presented
for 20 high-energy CID spectra. Spectra were chosen
from our vast library of high-energy CIO spectra ob-
tained on a four-sector instrument to encompass the
wide variety of fragmentation patterns and ion types
seen in high-energy CID and thus thoroughly evaluate
the performance of modifications to SEQUEST. Hence,
peptides with a range of masses and that contain basic
residues in various positions (including a neutral pep-
tide) were selected. Furthermore, the fragmentation
patterns and ion types examined are qualitatively simi-
lar to those observed with MALOI on double-focus-
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ing-orthogonal acceleration TOF [16] and collision cell
equipped reflectron TOF [18] instruments, although
these MALDI fragment ions tend to display more
abundant neutral-loss ion types.
Experimental
Search Algorithm and Under-Specified Parameters
The original SEQUEST algorithm [25] was modified so
that calculation of the following fragment ion types is
now enabled: a, b, c, d, o, w/ x, y/ z, and neutral
losses of NH 3 and H 20 from a, b, and y ions [29].
Either all of the ion types or a particular subset may be
used. Calculations of the corresponding mass-to-charge
ratio values were performed as previously described
[15/29]. The searching method uses the same two-part
scoring procedure [25]. Both the preliminary and final
scores are calculated with the relationships described
in Eng et a1. [25], except that the expanded set of ions
is included in the calculation. The mass measurement
tolerances can be set independently at any value for
precursor and fragment ion masses by using either the
monoisotopic or average mass scales [29].
These studies employ monoisotopic mass calcula-
tions and a high-energy fragment ion set that consists
of a, b, c, d, u, x/ y/ w/ z, and neutral loss of NH 3 and
H 20 from b ions. These ion types are assigned abun-
dances of 1.0/ 1.0/ 0.5/ 1.0/0.5/ 0.5/ 1.0/ 1.0/0.5/ 0.25/ and
0.25/ respectively, to approximate their typical relative
abundances in high-energy CID spectra and reduce the
possibility of false-positives that arise from sequences
that correlate implausibly with an experimental spec-
trum/ that is, correlation based on a preponderance of
ion types that are generally less common and also less
abundant (c, v/ x, and z) without accompanying ma-
jor ion types (a, b, d, w/ and y). The same mass
tolerances were employed for all searches in this study,
namely, ±0.5 u for the precursor ion and ±O.O u for
fragment ions. The ± O.O-u tolerance for fragment ions
acts as an effective tolerance of ± 0.5 u because of the
way the data are handled for rapid computer calcula-
tions. Fragment ion data are evaluated in l-u bins that
are offset by 1.0005 units. The offset ensures that the
distribution of possible monoisotopic fragment ion
masses is centered in a bin, whereas the ± O.O-u toler-
ance assures that no more than one bin is examined,
which thus yields a ± O.5-u tolerance from the center
of any given bin. Because > 95% of the possible
peptide fragment ion masses < 1500 u are constrained
by elemental composition to windows of width less
than ± 0.2 u [30] and fragment ion masses 150-1500 u
are measured to ± 0.3 u, a measured mass could be
evaluated in an incorrect bin only if its elemental
composition resulted in an expected mass that was
more than ± 0.2 u from the mean. With the 20 common
amino acids such cases are extremely rare; that is,
< 0.2 u from the mean requires more than 4 cysteines
or more than 6 aspartates, whereas > 0.2 u from the
mean requires more than 7 isoleucines, leucines, or
lysines.
SEQUEST normally searches for immonium ions as
part of the spectral preprocessing routine, but the
criteria that requires the presence or absence of partic-
ular amino acids in scored sequences based on immo-
nium ion peak detection are conservative. Currently,
only H, F, Y/ W, and M immonium ions are considered
solely because of their usual presence in all types of
tandem mass spectra. Because high-energy CID tends
to produce near-complete compositional information
from a combination of immonium and related ions in
the low mass-to-charge ratio range [31] and side-chain
loss ions in the high mass-to-charge ratio range [15],
SEQUEST was modified to allow amino acid composi-
tion or partial peptide sequence information to be
user-specified as an additional search constraint. Such
constraints may be manually added to the data, which
causes the immonium ion portion of the algorithm to
be overridden, and thus requires the presence of the
specified information in all scored sequences.
The specificity of proteases used to generate a given
peptide from its original protein may be included in
the search parameters as an option; that is, to narrow
the search to consider only those sequences that match
the specificity of the protease. In such cases incomplete
digestion is allowed to accommodate sequence exten-
sions on either side of a given expected cleavage site.
Databases
The OWL database version 26.0 (105/990 entries) was
obtained as an ASCII text file in the FASTA format
from the National Center for Biotechnology Informa-
tion (Washington, DC). OWL is a nonredundant
database comprised of protein sequences from the
GenBank (Release 88.0/ National Center for Biotechnol-
ogy Information, Washington, DC), SWISS-PROT (Re-
lease 31, University of Geneva, Geneva SWitzerland),
Protein Information Resource (Release 44, National Bi-
ology Resource Foundation, Georgetown University,
Washington, DC), and National Research Laboratory
(Release 18.0, Brookhaven National Laboratory,
Brookhaven, NY) databases. Species-specific databases
may be constructed by using a computer program to
perform keyword searches through a database to
transfer all sequences of a particular species to a sepa-
rate file. Human-specific (17,903 entries) and rat-
specific (2505 entries) sequence databases were pre-
pared by extraction of a species-limited set of entries
from the complete OWL database. The S. cerevisiae
sequence database (5252 entries) was obtained from
the Stanford yeast sequencing project.
Peptides
The peptides used in these studies (listed in Table 1)
were selected from fractions collected from reversed-
phase high-performance liquid chromatography sepa-
Table 1. Resul ts of the search of the OWL protein database (release 26; 105,990 sequences) by using high -energy em spectra
General search (low-energy ions') General search (high-energy ions') Trvpticsearch'' (high -energy ions' )
All species All species Single species All species Single species
Topranking
MW Species? Correct sequenced sequence Rank sc.: Rank sc; Rank sc; Rank fj,Cne Rank fj, ne
689.3 H (K) VWGSIK (G) KTGWVV 2 0.022 15(1 )f 0.056 4(1)f 0.010 1 0.005 1 0.043
809.4 H (R) LASYLDK (V) 1 0.007 1 0.009 1 0.041 1 0.171 1 0.306
818.5 H (K) CamLTAIVK(C) ACamlATVAV 3 0.062 3(1)Q 0.015 1 0.135 2(1 )Q 0.006 1 0.383
830.4 H (K) ILTDKLK (E) KDTILLAG > 500 0.000 1 0.013 1 0.051 1 0.088 1 0.171
842.4 R (K) LPAELATK (y) IIALLATQ 3 0.000 1 0.162 1 0.283 1 0.441 1 0.635
904.5 R (R)VITDLSSGI (-) 1 0.189 1 0.141 1 0.211 1 0.323 1 0.587
996.5 R (R) VSASDGFWK (S) 1 0.Q71 1 0.234 1 0.305 1 0.361 1 0.528
1003.5 Y (K) VTTNINWR SGGDVGGGGDL 10 0.046 1 0.027 1 0.061 1 0.140 1 0.281
1033.6 R (R) EFVPPFGIK (G) 1 0.155 1 0.214 1 0.322 1 0.365 1 0.463
1065.5 H (R) GDFCamlQVGR (N) TGTAWDGAFK 10 0.036 1 0.112 1 0.234 1 0.318 1 0.383
1067.5 Y (K) ESTLHLVLR (Ll ESTLHLVXR 1 0.000 1 0.015 1 0.444 1 0.015 1 0.605
1069.5 H (V) RPVAVALDTK (G) KPVARKASGR > 500 0.009 1 0.195 1 0.195
1081.5 Y (R)TLSDYNIQK(E) ATLSDYNLQK 1 0.000 1 0.012 1 0.299 1 0.012 1 0.464
1149.5 H (K) DRPFFAGLVK (y) SALSEFATLNP 61 0.063 1 0.118 1 0.130 1 0.294 1 0.367
1211.6 H (R) QITVNDLPVGR (S) KLTITNDHNR 2 0.009 1 0.261 1 0.261 1 0.256 1 0.482
1243.6 H (R) IQLVEELDR (A) GEGGAVSRTLTVP > 500 0.039 1 0.227 1 0.377 1 0.379 1 0.436
1261.9 Y (R) SDREYPLLlR (M) 1 0.100 1 0.348 1 0.371 1 0.456 1 0.482
1334.6 H (K) ATAWDGAFKEVK (Ll 1 0.338 1 0.369 1 0.385 1 0.384 1 0.523
1527.8 H (R) HLREYQDLLNVK (M) SSTKPSPNNANRVR > 500 0.094 1 0.369 1 0.438 1 0.419 1 0.569
1533.7 H (R) KVESLQEEIAFLK (K) 1 0.114 1 0.172 1 0.266 1 0.321 1 0.389
"The low-energy ion set included (b , y, and neutral loss of NH3 , H20 , and CO from b ions). The high-energy ion set included (a , b, c, a, v, W , x , y, Z, and neutral loss of
NHa and H20 from b ions).
bTryptic searches required all sequences to conform to trypsin protease specif icity, cleavage after R or K (not RP or KP), but missed cleavages allowed.
cH: human, R: rat, Y: yeast.
"Parentheses indicate residues before and after peptide. Cam= acrylamide-modifi ed Cys. All searches treated every Cys in the database as acrylamide modified.
eCl e n: difference in normalized cross-correlation value between the first and second ranked results. A value < 0.' indicates the first ranked result may be a
false-positive.
fRank based on the inclusion of amino acid composition information W derived from immonium and related ions.
QRank based on the inclusion of amino acid composition information Cam derived from neutral losses of the modified side chain from the precursor ion.
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rations of tryptic digests of 13 different proteins. The
human proteins Cu-Zn superoxide dismutase, cytoker-
atin (isotype unknown), annexin I (Iipocortin I), cy-
toskeletal tropomyosin, nucleoside diphosphate kinase
A, pyruvate kinase, natural killer cell enhancing factor
B, fibroblast nonmuscle tropomyosin, and vimentin are
from melanoma lysates isolated by two-dimensional
gel electrophoresis [5, 32]. The sialyltransferase was
purified from rat liver [33]. The yeast signal recogni-
tion particle subunits (68 and 19 ku) were purified by
immunoaffinity chromatography and electrophoresis
[34]. Yeast ubiquitin was obtained from Sigma Chemi-
cal Co. (St. Louis, MO).
High-Energy Tandem Mass Spectrometry
All positive-ion high-energy CID spectra were ac-
quired as previously described by using liquid sec-
ondary ionization in a thioglycerol matrix on a Kratos
Analytical instruments (Columbia, MD) Concept IIHH
four-sector mass spectrometer equipped with either a
static inlet probe and a 4% electro-optical multichannel
array detector [32, 35] or a continuous flow, liquid inlet
probe, and a rapid scanning charge-coupled device
array detector [5, 36, 37]. Spectra for all of the human
peptides except CamLTAIVK were obtained with the
instrument in the latter configuration by using 5-50
pmol of material. Spectra for the remaining peptides
were obtained with the instrument in the former con-
figuration by using 50-200 pmol of material. Signal-
to-noise ratios in all spectra are comparable to the
spectra shown in Figures 1 and 2.
Computation
All computer algorithms were written in the C-pro-
gramming language under the UNIX operating sys-
tem. All searches were performed on either a Digital
Equipment Corporation (Maynard, MA) DEC 3000/700
Alpha Workstation or a Sun Microsysterns (Mountain
View, CA) SPARC station IPX. A single unconstrained
search is completed in less than 2 or less than 12 min,
respectively. Search times decrease when species and
enzyme cleavage specificity constraints are added.
Results and Discussion
The objective of this investigation was to extend the
utility of the database searching algorithm SEQUEST
of Eng et al. [25] to include the capability to analyze
high-energy CID (E 1ab = 1-8 keV) spectra of peptides.
Following suitable modification, the performance of
SEQUEST has been evaluated by performing of
searches using 20 high-energy CID spectra of a variety
of amino acid compositions and peptide sequences. In
these investigations the correct sequence was ranked
first in 90% (18 of 20) of unconstrained searches of the
entire OWL database as shown in Table 1; 65% (13 of
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Figure 1. High-energy collision-induced dissociation spectrum obtained from 5-50 pmol of a peptide derived from trypsin digestion
of fibroblast nonmuscle tropomyosin isolated from human melanoma cells [4]. MH+ = 1243.7.
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Figure 2. High-energy collision-induced dissociation spectrum obtained from 5-50 pmol of a peptide derived from trypsin digestion
of Cu-Zn superoxide dismutase isolated from human melanoma cells [4]. Fragment ion assignments for the top-scoring, but incorrect,
sequence are in shaded gray. MH+ = 689.3.
20) of the search results have ~Cn values > 0.1, which
indicates that false-positives are unlikely. Once the
searches are limited by enzyme specificity and species
of origin the correct sequence is ranked first in 100%
09 of 19) of the searches and 95% (18 of 19) have ~Cn
values > 0.1. The remaining peptide resulted from a
nonspecific enzyme cleavage.
Because the high-energy fragmentation behavior of
certain types of peptides is qualitatively similar to the
low-energy case with just the addition of certain ion
types (c, d, v, w, x, z ), the low-energy form of the algo-
rithm could be expected to have difficulty scoring the
correct sequence from a high-energy CIO spectrum.
False-positives might arise from incorrect sequences
that preferentially fit the data produced by the addi-
tional ion types. Following modification of the algo-
rithm to consider the additional ion types that might
be present in the data, false-positives should be dimin-
ished greatly because the correct sequence could be
expected to fit the data much better than any incorrect
sequences (unless the data are ambiguous). These ex-
pectations are borne out by searches that use the high-
energy CIO spectrum from the fibroblast nonmusc1e
tropomyosin peptide IQLVEEELOR (mlz 1243.6),
shown in Figure 1, which provides a textbook example
of the kind of fragmentation patterns frequently ob-
served under high-energy CIO conditions. When this
particular spectrum was employed in an uncon-
strained search of the OWL database 005,990 nome-
dundant entries) by using SEQUEST in a low-energy
form (that is, an ion set consisting of b, y, and neutral
loss of NH 3, H 20 , and CO from b ions) with the same
mass tolerances as the high-energy form, the correct
sequence was not even ranked among the top 500
sequences in the preliminary search. As shown in
Table 1, when the low-energy form of SEQUEST is
applied to all 20 of the test spectra for unconstrained
searches, only 45% (9 of 20) give the correct result
ranked first and only 25% (5 of 20) yield an indication
that false-positives are unlikely with ~Cn values > O.l.
Consequently, the high-energy modifications to the
algorithm produced the correct result with substan-
tially stronger scores and substantially reduced the
possibility that results could be false-positives.
It is important to note that solely on the basis of the
information present in the CIO spectrum shown in
Figure 1, the N-terminal order of IQ cannot be differ-
entiated from LQ, IK, LK, QL, or KL. This particular
ambiguity results from the inability of side-chain loss
ions to be formed from an N-terminal amino acid and
the isobaric pairing of IlL and Q/K. The additional
isobaric permutations QI and KI can be eliminated as
possibilities by the presence of the w 9 ion, which
allows us to distinguish between I and L at the second
J Am Soc Mass Spectrom 1996, 7, 1089-1098 SEARCH OF DATABASES WlTH HIGH-ENERGY cro SPECTRA 1095
position but not between Q and K. Also, possibilities
that contain K are unlikely due to the paucity of ion
series with N-terminal charge retention (a, b, c, and d).
However, in this example none of these theoretical
possibilities complicates the search because only the
IQ-containing sequence exists in the database.
Spectra That Are Not Correlated Readily
Inspection of Table 1 reveals that despite high-energy
modifications to SEQUEST, 2 out of 20 (10%) uncon-
strained searches of the entire OWL database still did
not rank the correct sequence first. However, in both of
these searches the small ~Cn values raise the real
possibility of these being false-positive rankings.
One of these spectra is shown in Figure 2. It is the
high-energy CID spectrum obtained from the Cu-Zn
superoxide dismutase peptide VWGSIK (m/z 689.3).
In this example the correct sequence was ranked fif-
teenth in an unconstrained search with ~Cn = 0.056.
To illustrate the factors involved to obtain such a
result, the fragment ion assignments for both the cor-
rect sequence and the top scoring sequence
VVSGSLGA are shown in Figure 2. This example illus-
trates the difficulty of using a CID spectrum where the
spectrum may not uniquely correlate to a sequence in
the database, particularly if some sequence ions are
either weak or missing. Searches with spectra from
short peptides more frequently encounter this prob-
lem, because the database is more likely to contain all
the combinatorially possible sequences of amino acids
of a given length. However, this spectrum contains a
near-complete set of amino acid composition ions. In
particular, ions at m r« 117, 130, 159, and 170 together
are demonstratively characteristic of the presence of
tryptophan in a peptide. When this Trp composition
information is included in the search to override the
algorithm's conservative immonium ion detection rou-
tine and require all scored sequences to contain trypto-
phan, the correct sequence is ranked first, whereas
three other sequences-VVSWAQ, VWSVAGA, and
VWSGKL-could be considered as false-positives be-
cause their ACn scores are within 0.1 of the correct
sequence. Because the peptide used to obtain this spec-
trum was derived from trypsin digestion of a protein
isolated from human melanoma cells, this additional
information can be used to limit the sequences consid-
ered in a search. Table 1 shows that the correct se-
quence ranks fourth, first, and first when only se-
quences are considered that are human, trypsin cleav-
ages of proteins from all species, or trypsin cleavages
of human proteins, respectively. In each case, the like-
lihood of a false-positive result is flagged by ~Cn
scores < 0.1.
Evaluation of the results from the other uncon-
strained search in which the algorithm ranks an incor-
rect sequence first, reveals high rankings for sequences
with significant structural similarity. An unconstrained
search of the entire OWL database with the CID spec-
trum for the annexin I (Iipocortin I) peptide
CamLTAIVK (m/z 818.5, where Cam is acrylamide-
modified Cys with a modified mass, MW = 174) [32]
ranks the incorrect sequences ASETALVK and ADT-
TAIVK first and second, respectively. The sequence
ADTTAIVK also ranks first in a trypsin-specific search,
whereas the correct sequence ranks second. The negli-
gible difference in ACn score of these three sequences
is a result of the near sequence identity in the last five
residues in all three sequences. However, the only ions
present in the spectrum that allow unambiguous as-
signment of CamLTVAIK over the other two are ions
that represent unusuallosses of -118.0, -105.1, -72.1,
and -44.1 from the precursor ion. These ions indicate
fragmentation in the side-chain (- C 4H sNOS,
- C3H7NOS, - C3H6NO, and - CH2NO, respec-
tively) characteristic of an acrylamide-modified cys-
teine residue [32]. We typically find acrylamide-mod-
ified cysteine residues in proteins, such as this one,
which are isolated by sodium dodecylsulfate-poly-
acrylamide gel electrophoresis [5, 32]. The ability of
SEQUEST to consider such side-chain losses from the
precursor ion is not currently incorporated. Nonethe-
less, inclusion of composition information, Cam, in a
general search to constrain the sequences considered
enables the algorithm to rank Caml,TVAIK first
(LCamAITVQ and CamLTALVK rank second and
third, respectively, with ACn scores < 0.04). Further-
more, if the species of origin of the protein without
compositional information is added to the search, then
the correct sequence ranks first unambiguously in both
general and trypsin-specific searches, because no possi-
ble false-positives are indicated by the ~Cn scores.
Spectra with Potential False-Positive Identifications
Although 18 out of 20 general searches ranked the
correct sequence first once SEQUEST was modified to
include high-energy ion types, the possibility of a
false-positive identification was raised in 5 of these
searches by ~Cn scores < 0.1. In two of these five
searches the correct isomer of the isobaric pair Leu and
lIe (both have residue mass 113) was identified when
sequences were found whose only difference was Leu,
Ile, or X (represents an ambiguity between lIe and
Leu). In the character representations of amino acids in
sequence databases the letter code X signifies any
unidentified amino acid. However, in the search algo-
rithm the character X is considered to be either Leu or
Ile, but d and w ions, which can distinguish Leu or Ile,
are not scored in favor of X. For example, in a search
with the high-energy CID spectrum from the ubiquitin
peptide ESTLHLVLR (m/z 1067.5) the correct answer
was ranked first, over a second ranking sequence of
ESTLHLVXR. The correct answer had both a higher
preliminary score and cross-correlation score that iden-
tified one more fragment ion, the w 2 ion for leucine.
Because the ACn = 0.015, this sequence choice was
flagged as a possible false-positive. In the search with
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the CIO spectrum from the ubiquitin peptide
TLSOYNIQK (m/ z 1081.5), the correct sequence ranked
first and the second ranking sequence wa s found to be
TLSOYNLQK. Because the ~Cn = 0.012 the result is
again flagged as a possible false-positive, but the pres-
ence of a w 3 ion for isoleucine allows the correct
sequence to be confirmed. Both of these examples
demonstrate the exquisite sensitivity possible with this
method to search the protein database and the level of
struc tural information present in a high-energy CIO
mass spectru m. For the purpose of protein identifica-
tion it is noteworthy that for both of these ubiquitin
peptides the isomeric potential false-positives are from
the same protein but are derived from different species.
Three other unconstrained searches ranked the cor-
rect sequence first, but also indicated the possibility of
false-positive identifications w ith ~Cn scores < 0.1.
The sequence ranking obtained from searches that used
spectra that represented the sequences LASYLOK,
ILTOKLK, and VTTNINWR (m/z 809.4, 830.4, and
1003.5, respectively) had 5, 13, and 7 other sequences,
resp ect ively, with ~Cn scores w ithin 0.1 of the correct
sequence. The five other sequences in the search with
the cytokeratin peptide LASYLOK search were from
LASYLSR, SPSYLOK, LASYLRS, LASYLKO, and
SPSYLEN. These sequences not only have differences
from the correct sequence either in the firs t two amino
acids or in the last two amino acids, but also have
incorrect pai rs of amino acid s that are isobaric with the
correct pa irs. Because aI ' b1, and c1 ions are typically
not present in high-energy CIO spectra, the correct
sequence LASYLOK is scored higher based on the
presence of only one or tw o additional fragment ions
in the spectru m. The results of the search with the CIO
spectrum from the cytoskeletal tropomyosin peptide
ILTOKLK similarly suffer from the combinatorial pos-
sibilities created by amino acids present in the peptide
that are isobaric with another amino acid: three
residues are either leucine or isoleucine, and two
residues are lysine (isobaric with glu tamine). The re-
sults of the search with the CIO spectrum from the
68-ku signal recognition particle subuni t peptide
VTTNINWR contain seven sequences with ~Cn scores
wi thin 0.1 of the correct sequence due to the inordi-
nately large number of fragment ions in the spectrum.
The spectru m not only contains complete or near-com-
plete series of fragment ion s from the a, b, v, w, x, y,
and z families, but also contains numerous internal
acyl fragment ions [15, 29] (the search algorithm cur-
rently do es not consider internal acyl ion s). Taken
together, these attributes enable several similar se-
quences to score well in relation to the cor rect se-
quence. However, it is important to note that for all
three pep tides LASYLOK, ILTOKLK, and V1TNINWR,
once inform ation that concerns the species from which
the proteins were isolated and the fact that the pep-
tides were derived by tryptic digestion are included in
the search parameters, there is no ind ication of possi-
J Am Soc M ass Spectrom 1996, 7, 1089-1098
ble false-positive results because the ~Cn scores are all
> 0.1.
Conclusions
These studies have substantiated that the peptide se-
quence information inherent in high-energy CIO spec-
tra is highly specific and can be used to identify amino
acid sequences uniquely in the protein database. The
resulting power of discrimination is such that 90% (18
of 20) of our spectra were correlated by SEQUEST to
the correct sequence in a database of 105,990 nonre-
dundant protein sequences (OWL, release 26) without
the need to provide the cleavage-specificity of the
enzyme used to generate the peptide nor the species
from which the original protein wa s isolated. It is clear
that incorporation of additional diagnostic features
from high-energy CIO spectra that are used routinely
in manual interpretation will extend the usefulness to
processed and modified pep tides such as those that
occur as putative MHC antigens and peptides that
bear posttranslational or xenobiotic modifications.
However, the high success rate observed thus far has
some important implications. Search strategies need
not be hindered by the occurrence of nonspecific cleav-
ages that result from protease infidelity. Sequence con-
servation across species allows a tandem mass spec-
trum to be correlated to a homologous protein from a
species other than the one being studied, particularly
when the protein is unknown in the species being
studied. Among cross-species functional protein he-
mologs sequence identity is typically > 25%, and we
commonly find completely conserved try p tic peptides
because there tend to be clusters of consecutive se-
qu ence identity. Furthermore, the detailed fragmenta-
tion information present in a high-ene rgy CIO spec-
trum may allow the presence of a modification to be
detected as part of spectral preprocessing to establish
criteria for the search algorithm to locate the specific
modification sites. Finally, explicit and accurate identi-
fication of the location and nature of polymorphic
variations in a protein [38], as well as tolerance of
sequence errors in the database, will be possible wi th
futu re mod ifications to SEQUEST because of the dis-
criminating power of the information in a tandem
ma ss spectrum.
The current and expected future size of sequence
databases also raises important issu es. A large major-
ity of the combinatorially possible linear sequences of
amino acids, greater than eight residues in length, are
not cu rrently represented in protein databases. More-
over , the sheer enormity of the combinatorial possibili-
ties (20", for peptide length n) combined with the fact
that sequences of proteins wi th common function from
evolutionarily related sp ecies often have sequence sim-
ilar ity suggests that th is wi ll continue to be the case
not only when genomes are completely sequenced, but
also as genome sequencing is extended beyond those
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projects currently underway. Even though a tandem
mass spectrum may not be unique for a single amino
acid sequence when all the combinatorially possible
amino acid sequences are considered, it may very well
be unique to a sequence within the genome of a single
species. Until the genome from an investigator's species
of interest is completely sequenced, however, database
searches typically will be conducted through the entire
collection of known sequences from all species. Under
such conditions, it is likely that subtle differences
between conserved sequences may be observed such
as the exchange of Leu and He seen in the foregoing
ubiquitin examples (m/z 1067.5 and 1081.5 in Table n
In this case the information necessary to differentiate
the two isomers is present in the high-energy CIO
spectra, and SEQUEST ranks the correct sequence first
and flags the sequence similarity of the two ubiquitin.
Other uncertainties in sequence assignment presented
by weak or missing sequence ions in the tandem mass
spectrum or isobaric amino acid residues and amino
acid combinations in similar sequences may be incon-
sequential when only one sequence present in a
database uniquely fits the spectrum. In the event se-
quence similarities exist in the complete database that
cannot be resolved by the detailed fragmentation infor-
mation present in the high-energy CIO spectra, more
restrictions, such as restraining a search to a single
species or utilizing proteolytic cleavage information,
may provide an unambiguous answer.
The fragmentation patterns produced by the variety
of mass spectrometric techniques now available could
be analyzed best by allowing consideration of all types
of fragment ions. In this manner tandem mass spectra
of peptides obtained by employing different internal
energy deposition conditions could be used with the
algorithm to screen sequence databases readily in an
automated fashion with the need for manual evalua-
tion only in the limited number of cases where the
algorithm flags the search result as a possible false-
positive.
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